FIW First Trust Water ETF
- 102.650
- -0.230-0.22%
Jefferies Downgrades Agilent Technologies to Hold, Lowers Price Target to $135
Jefferies analyst Brandon Couillard downgrades Agilent Technologies (NYSE:A) from Buy to Hold and lowers the price target from $152 to $135.
Are Water Stocks the Next AI Play? JPMorgan Predicts Data Centers Will Consume 450 Million Gallons of Water Daily
Wall Street banks are in a frenzy over "The Next AI Trade," piling into the 'Powering up America' investment themes. These include power grid companies, commodities such as copper and uranium, as well as artificial intelligence chipmakers.
Salesforce And Celsius Were Among The 10 Biggest Large Cap Losers Last Week: Are These In Your Portfolio?
These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?MongoDB, Inc. (NASDAQ:MDB) shares tumbled 31.63% after the company issued weak Q2 and FY25 guidance. A
Most S&P 500 Firms Beat EPS Expectations but Fell Short on Revenue This Week - Earnings Scorecard
Qualigen Therapeutics Receives Nasdaq Notice of Delisting Determination
Tech, Blue Chip Stocks Drop; Small Caps, Real Estate Rebound As Yields Ease; Solar Industry Shines: What's Driving Markets Thursday?
Wall Street experienced another decline on Thursday, with major large-cap indices affected by a downturn in the tech and communication services sectors. Investors shifted their focus to market areas t
Cracking The Code: Understanding Analyst Reviews For Agilent Technologies
Analysts' ratings for Agilent Technologies (NYSE:A) over the last quarter vary from bullish to bearish, as provided by 9 analysts.Summarizing their recent assessments, the table below illustrates the
Ecopetrol Cut to Sell Equivalent at BofA as Macro Concerns Muddy the Waters
Predictive Oncology, Augmedix, Cue Health Among Healthcare Movers
Agilent Technologies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 7.09% Baird $147 → $136 Maintains Outperform 04/10/2024 6.3% Barclays $125 → $135 Maintains Und
Today's Morning Movers and Top Ratings: HPQ, MRNA, PATH, AZN and More
Moderna stock increased by 2.9% as a Financial Times report indicated that the U.S. government is close to finalizing a deal to finance a late-stage trial of the company's pandemic bird flu vaccine.
Wall Street On Backfoot As Traders Sweat Over Key Inflation Data: Economist Warns Stock Rally May Stumble If Bond Yield Crosses This Level
U.S. stocks are likely to remain weak on Thursday, major index futures indicated, as lower bond yields stayed elevated and mixed earnings dampened sentiment. On traders' radar are key inflation data f
Insiders Buying Hilton Worldwide And 2 Other Stocks
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the st
Xylem Reiterates 2024 Guidance As Previously Provided On May 2, 2024; Introduces Long-Term Financial Framework
Xylem's long-term financial framework anticipates annual organic revenue growth in the range of 4 percent to 6 percent, with approximately 1 percent from implied revenue synergies offset by the impact
Earnings Call Summary | Agilent Technologies -7% After Q2 2024 Earnings
The following is a summary of the Agilent Technologies, Inc. (A) Q2 2024 Earnings Call Transcript:Financial Performance:Agilent Q2 revenue was $1.573 billion, a 7.4% decrease YoY, with earnings per sh
Agilent Down 14% Following Revised 2024 Guidance
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersOneMedNet (NASDAQ:ONMD) shares increased by 52.3% to $2.97 during Wednesday's after-market session. The company's market cap stands at $70.8 million. Kintara Therapeutics (NASDAQ:KTRA) shares r
Agilent Shares Are Trading Lower Following Mixed Q2 Earnings.
Agilent Shares Are Trading Lower Following Mixed Q2 Earnings.
Xylem Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/29/2024 19.53% Argus Research $146 → $165 Maintains Buy 05/03/2024 17.36% RBC Capital $157 → $162 Maint
Wall Street Set To Open Weaker As Bond Yields Rise, Meme Rally Cools: Analyst Says Stick With What's Working Amid Volatility
U.S. stocks are poised to open lower on Wednesday following the boost from the tech rally in the previous session. The spotlight will likely be on bond yields, which have climbed in recent sessions on